RecruitingNCT06270537
Post-market Clinical Trial of the Dominus® Stent-Graft
Multicenter Study Collecting Post-market Clinical Data on the Dominus® Stent-Graft for Treating Thoracic Aortic Diseases
Sponsor
Braile Biomedica Ind. Com. e Repr. Ltda.
Enrollment
100 participants
Start Date
Oct 24, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
Real-world clinical trial evidence post-market, evaluating the safety and efficacy of the Dominus® StentGraft Endoprosthesis in treating thoracic aortic diseases, following the Instructions for Use
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- 18 years of age or older;
- Patients treated with the Dominus® Stent-Graft Endoprosthesis in accordance with its Instructions for Use;
- Patient available for appropriate follow-up times for the study duration;
- Informed patient about the nature of the study, agreeing to its provisions, and signing the informed consent.
Exclusion Criteria2
- Patient currently participating in another clinical study of drug or medical device;
- Life expectancy less than 12 months.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEStent-Graft Dominus® Endoprosthesis
Placement of the Dominus® Stent-Graft for endovascular repair of diseases of the Thoracic Aorta
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06270537